Vigabatrin: a new antiepileptic medication.
Marion Merrell Dow Research Centre, Winnersh, UK.
J
J
Mumford
O
O
Dulac
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000328:Adult; D000614:Aminocaproates / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D002648:Child; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin